A detailed history of Muhlenkamp & CO Inc transactions in Mckesson Corp stock. As of the latest transaction made, Muhlenkamp & CO Inc holds 38,607 shares of MCK stock, worth $22.4 Million. This represents 6.16% of its overall portfolio holdings.

Number of Shares
38,607
Previous 38,636 0.08%
Holding current value
$22.4 Million
Previous $22.6 Million 15.44%
% of portfolio
6.16%
Previous 7.38%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$479.06 - $630.38 $13,892 - $18,281
-29 Reduced 0.08%
38,607 $19.1 Million
Q2 2024

Jul 16, 2024

SELL
$518.81 - $607.81 $28,534 - $33,429
-55 Reduced 0.14%
38,636 $22.6 Million
Q1 2024

Apr 23, 2024

BUY
$473.42 - $539.26 $98,944 - $112,705
209 Added 0.54%
38,691 $20.8 Million
Q4 2023

Jan 08, 2024

BUY
$437.42 - $470.64 $94,045 - $101,187
215 Added 0.56%
38,482 $17.8 Million
Q3 2023

Dec 06, 2023

SELL
$402.4 - $446.42 $23,339 - $25,892
-58 Reduced 0.15%
38,267 $16.6 Million
Q2 2023

Jul 14, 2023

BUY
$354.01 - $427.31 $26,904 - $32,475
76 Added 0.2%
38,325 $16.4 Million
Q4 2022

Jan 31, 2023

BUY
$346.68 - $397.58 $13,867 - $15,903
40 Added 0.1%
38,249 $14.3 Million
Q3 2022

Nov 01, 2022

BUY
$321.25 - $373.84 $91,556 - $106,544
285 Added 0.75%
38,209 $13 Million
Q2 2022

Jul 18, 2022

SELL
$300.57 - $336.42 $8.31 Million - $9.31 Million
-27,661 Reduced 42.18%
37,924 $12.4 Million
Q1 2022

Apr 01, 2022

BUY
$244.61 - $310.48 $20,791 - $26,390
85 Added 0.13%
65,585 $20.1 Million
Q4 2021

Mar 29, 2022

SELL
$198.21 - $248.9 $9,514 - $11,947
-48 Reduced 0.07%
65,500 $16.3 Million
Q3 2021

Dec 10, 2021

SELL
$188.42 - $208.66 $15,638 - $17,318
-83 Reduced 0.13%
65,548 $13.1 Million
Q2 2021

Aug 18, 2021

BUY
$184.89 - $202.68 $15,345 - $16,822
83 Added 0.13%
65,631 $12.6 Million
Q1 2021

Aug 18, 2021

SELL
$169.52 - $196.53 $933,546 - $1.08 Million
-5,507 Reduced 7.75%
65,548 $13.3 Million
Q4 2020

Feb 11, 2021

BUY
$143.79 - $183.66 $29,333 - $37,466
204 Added 0.29%
71,055 $12.4 Million
Q3 2020

Nov 13, 2020

BUY
$140.89 - $159.9 $43,957 - $49,888
312 Added 0.44%
70,851 $10.6 Million
Q2 2020

Aug 20, 2020

SELL
$125.49 - $164.68 $250 - $329
-2 Reduced -0.0%
70,539 $10.8 Million
Q4 2019

Feb 20, 2020

BUY
$130.23 - $153.27 $390 - $459
3 Added 0.0%
70,541 $9.76 Million
Q3 2019

Nov 27, 2019

BUY
$134.24 - $148.53 $149,006 - $164,868
1,110 Added 1.6%
70,538 $9.64 Million
Q2 2019

Aug 28, 2019

SELL
$112.47 - $134.93 $19,344 - $23,207
-172 Reduced 0.25%
69,428 $9.33 Million
Q1 2019

May 23, 2019

SELL
$111.86 - $136.3 $127,744 - $155,654
-1,142 Reduced 1.61%
69,600 $8.15 Million
Q3 2018

Nov 13, 2018

SELL
$123.14 - $138.52 $42,852 - $48,204
-348 Reduced 0.49%
70,742 $9.38 Million
Q1 2018

May 11, 2018

BUY
$138.75 - $176.72 $158,591 - $201,990
1,143 Added 1.63%
71,090 $0
Q4 2017

Feb 14, 2018

SELL
$135.02 - $162.6 $136,235 - $164,063
-1,009 Reduced 1.42%
69,947 $10.9 Million
Q3 2017

Nov 13, 2017

SELL
$146.0 - $161.87 $59,714 - $66,204
-409 Reduced 0.57%
70,956 $10.9 Million
Q2 2017

Aug 11, 2017

BUY
N/A
71,365
71,365 $11.7 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $83.3B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Muhlenkamp & CO Inc Portfolio

Follow Muhlenkamp & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Muhlenkamp & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Muhlenkamp & CO Inc with notifications on news.